An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32745669.
- Also identified by DOI 10.1016/j.radonc.2020.07.051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our study is the first to report an especially high rate of grade 2 or worse radiation pneumonitis in patients treated with thoracic radiotherapy and simultaneous Osimertinib, despite total lung V5, V20 and MLD seeming unlikely to induce radiation pneumonitis.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Radiation Pneumonitis